Home>News> Novartis whacking nearly 2,000 manufacturing jobs to pump up margins

Novartis whacking nearly 2,000 manufacturing jobs to pump up margins

Novartis’ traditional pill manufacturing will shoulder the brunt of a cost-cutting effort announced Tuesday as it looks to a future in biologic drugs and higher margins.
 
The Swiss drugmaker said four plants in Switzerland and one in the U.K. would be hit with job cuts as it trims down a manufacturing network that operates below capacity while generics steal market share and patients rely more on more complicated injected drugs.

Tags: